![]()
- Sales of New Homes Forecast to Rise 2%
- Americans Ditch Planes for Trains this Thanksgiving
- Half of Banks' Losses May Still Be Hidden: IMF Head
- Obama Reiterates Commitment to Boost US-India Ties
- FDIC's Bair Cautions on Risks in Bank Break-Up Plan
- Wednesday's Economic News Crunch Could Tilt Markets
- Call Me Crazy: Confessions of a Black Friday Shopper
- Starbucks Eyes China as Next Major Market
- Citi Mortgage Reveals Something the US Treasury Won't
- Citi Mortgage Reveals What Treasury Won't
- S&P to Hit 1,200 by Year-End: Chief Investor
- Amended Berkshire Hathaway Filing Indicates No Secret Stock Stakes at End of Q3
- Facebook's Biggest-Ever Holiday Shopping Season
- Facebook's New Dual Class Structure - Slow Steps to an IPO
- 5 Big Bank Stocks Investors Should Consider: Strategists
- Gambling Drunk, Texting to Live And America's On Sale - Your Emails
- Nov. 24: Unusual Volume Leaders
- NBA D-League On The Rise
MOST SHARED
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- Wednesday's Economic News Crunch Could Tilt Markets
- NBA D-League On The Rise
- The Social Media Gaming Threat
- Obama Reiterates Commitment to Boost US-India Ties
- Stifling Anger at Work Can Kill, Survey Finds
- Japan Export Rebound Eases Fear of New Recession
- Australia Wheat Exporters Face Challenges: GrainCorp
Stocks on the move Real-time Equity news U.S. stock market report 0647 ET 02Nov2009-Barron's bullish on Progressive Corp ------------------------------------------------------------------------------ Barron's issued a bullish comment about Progressive Corp , writing that the auto insurance company was poised to expand its revenue and earnings for the first time in several years. The financial publication added that the company's stock looked appealing because it traded at a historically low valuation. For details, see Shares of Progressive closed Friday at $16. Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net 0643 ET 02Nov2009-Human Genome rallies after lupus drug trial data ------------------------------------------------------------------------------ Shares of Human Genome Sciences Inc soared in premarket trading on Monday, after the company said its experimental lupus drug was successful in a second clinical trial. The data paves the way for approval of the first new treatment for lupus in 50 years. For details, see The stock was up 36 percent to $25.49 before the bell. Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net 0637 ET 02Nov2009-CIT files for bankruptcy ------------------------------------------------------------------------------ CIT Group Inc on Sunday filed for bankruptcy protection, in one of the largest filings in the United States. Under a prepackaged plan, the lender plans to reduce its total debt by about $10 billion. For details, see Shares of CIT shed 46 percent to 39 cents in premarket trading. Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net 0633 ET 02Nov2009-Economic indicators for Nov. 2 ------------------------------------------------------------------------------ Economic indicators on tap for Monday include pending home sales data for September, construction spending data for September and October ISM manufacturing data. For details, see Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net 0629 ET 02Nov2009-Earnings diary for Nov. 2 ------------------------------------------------------------------------------ Companies scheduled to report quarterly results on Monday include Ford Motor Co, Clorox, Consolidated Edison, Dean Food and Humana, among others. For details, see Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net Keywords: MARKETS STOCKSNEWS COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved.
The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
- Remember when auto shows were major events where new models could generate buzz?
- CNBC’s Mike Huckman visits a cutting-edge plant to see how the flu vaccine of the future is being made.
- People who bottle up their anger at work are up to five times more likely to suffer a heart attack, a study found.
- Playboy will outsource its publishing operations in a bid to become profitable again.
- A new McDonald's in Manhattan is the nation's first to sport a sleek, chic interior imported from stores in London and Paris.
- For nearly three decades, these on-call experts have been dishing advice on how to – and not to – cook turkey.











